 "Cipla's Goa plant")
Shares of Cipla have surged 7% to Rs 563 per share, bouncing back 8% from their early morning low of Rs 520 per share on the BSE, after the pharmaceutical company reported a consolidated net profit of Rs 1.79 billion in March quarter (Q4FY18) against a net loss of Rs 620 million in the same quarter last year.
Total income from operations grew 3.2% at Rs 36.98 billion as compared to Rs 35.82 billion over the previous year quarter. Key markets including India and South Africa continued to deliver strong growth, Cipla said in a statement.
Analysts on
Total income from operations grew 3.2% at Rs 36.98 billion as compared to Rs 35.82 billion over the previous year quarter. Key markets including India and South Africa continued to deliver strong growth, Cipla said in a statement.
Analysts on
